AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Appride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Apkavit Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Appride M 1mg/500mg Tablet SR

Diabetac Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabetac Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Appride M 1mg/500mg Tablet SR

The provided text is "undefined," offering no content to rephrase.

Uses of Appride M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Appride M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Appride M 1mg/500mg Extended-Release Tablet with food.

Common Side effects of Appride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Appride M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Appride M 1mg/500mg Sustained-Release Tablet with food.

How Appride M 1mg/500mg Tablet SR works:

Appride M SR tablets (1mg/500mg) combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Appride M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Appride M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Appride M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Appride M 1mg/500mg SR tablets; dosage modification may be necessary. Consult a physician for guidance. Appride M 1mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Appride M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Appride M 1mg/500mg Tablet SR :

Should you forget a dose of Appride M 1mg/500mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Appride M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Appride M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Appride M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Appride M 1mg/500mg Tablet SR and seek immediate medical attention.
Appride M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Appride M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Appride M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Appride M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Appride M 1mg/500mg SR tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Appride M 1mg/500mg Table...
77
MRP 89
13% off